Pharmacology In Drug Discovery And Development ((install))

A wide TI (e.g., Penicillin: TI > 100) is safe. A narrow TI (e.g., Digoxin for heart failure: TI ~ 2) is dangerous. Pharmacologists generate DRCs for both efficacy and toxicity in at least two animal species (typically rodent and non-rodent) before regulatory filing.

At the heart of this journey is .

The old model was "one drug fits all." Modern pharmacology is rewriting that script. pharmacology in drug discovery and development

What the body does to the drug.

Without the rigorous study of pharmacodynamics and pharmacokinetics, we would have no way to distinguish a potential cure from a dangerous poison. It is the silent engine that powers the journey from a scientist's bench to a patient's bedside. A wide TI (e

This editorial in Clinical Pharmacology in Drug Development explores 2025 as a "pivotal" year where mechanistic modeling and computational innovation coalesced to fundamentally re-shape how drugs are developed. At the heart of this journey is